Anti-Atg2A Antibody (23001)

Anti-Atg2A Antibody (23001)

Product No.: 23001

- -
- -
Target
Atg2A
Product Type
Polyclonal
Applications
WB
,
ICC/IF

- -
- -
Select Product Size

Data

Immunoblotting: use at 1-2ug/ml. A band of ~213kDa is detected. Detection of Atg2A in 20ug HeLa cell lysate.Immunoblotting: use at 1-2ug/ml. A band of ~213kDa is detected. Detection of Atg2A in 20ug HeLa cell lysate.
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
Synthetic peptide corresponding to amino acids at the C-terminus of human ATG2A.
Product Concentration
1.0 mg/ml
Formulation
PBS, pH 7.4, 50% glycerol, 0.09% sodium azide.
State of Matter
Liquid
Product Preparation
Purified by peptide immuno-affinity chromatography
Storage and Handling
This antibody is stable for at least one (1) year at -20°C.
Regulatory Status
For in vitro investigational use only. Not for use in therapeutic or diagnostic procedures.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
Immunoblotting: use at 1-2ug/mL. A band of ~213kDa is detected.

These are recommended concentrations.

Endusers should determine optimal concentrations for their applications.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
This antibody recognizes human Atg2A.
Background
Autophagy is a catabolic process that results in the degradation of bulk cytoplasmic contents within autophagosomes and lysosomes. Two human Atg2 homologs (Atg2A, Atg2B) are critical for autophagosome formation as silencing of both results in the accumulation of unclosed autophagic structures. Starvation-induced autophagy targets Atg2A to the initiation site of autophagosome biogenesis, where it associates with DFCP1, WIPI-1, and other autophagy- related proteins. Atg2 proteins also function in lipid droplet metabolism as depletion of both Atg2A and AtgB results in changes in the size, number, and distribution of lipid droplets. An increase in Atg2A expression during etoposide- and doxorubicin-induced apoptosis suggests that Atg2A may be a useful indicator of topoisomerase II inhibitor-mediated apoptosis.
Function
Lipid transfer protein involved in autophagosome assembly (PubMed:28561066, PubMed:31271352, PubMed:30952800). Tethers the edge of the isolation membrane (IM) to the endoplasmic reticulum (ER) and mediates direct lipid transfer from ER to IM for IM expansion (PubMed:31271352, PubMed:30952800). Binds to the ER exit site (ERES), which is the membrane source for autophagosome formation, and extracts phospholipids from the membrane source and transfers them to ATG9 (ATG9A or ATG9B) to the IM for membrane expansion (PubMed:31271352, PubMed:30952800). Lipid transfer activity is enhanced by WIPI1 and WDR45/WIPI4, which promote ATG2A-association with phosphatidylinositol 3-monophosphate (PI3P)-containing membranes (PubMed:31271352). Also regulates lipid droplets morphology and distribution within the cell (PubMed:22219374, PubMed:28561066). {PubMed:22219374, PubMed:28561066, PubMed:30952800, PubMed:31271352}.
NCBI Gene Bank ID
UniProt.org
Research Area
Autophagy

References & Citations

General Western Blot Protocol
ICC/IF

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.